Keeping InSight

In this episode, we will feature a compelling discussion with Dr. Teresa Quattrin, MD on addressing the challenges posed by social determinants of health in the screening process for Type 1 Diabetes (T1D). Our MSL co-hosts, Anil Jacob, PharmD, and Mary Voelmle, NP, CDCES, engage Dr. Quattrin in an insightful conversation about breaking down barriers and overcoming challenges faced by under-resourced communities. Dr. Quattrin sheds ...

In this episode our hosts Jessica Driscoll, DNP (US Transplant MSL) and Katie McMurry, PharmD (US Transplant MSL) have a conversation with Amanda Ferraro, a patient advocate for chronic graft-versus-host disease and the complications associated with stem cell transplant. A leukemia and stem cell transplant survivor, Amanda lives with chronic graft-versus-host disease and speaks candidly about her journey. Her mission is to help oth...

In this episode our hosts Katie McMurry, PharmD (US Transplant MSL) and Amber Lawson, PharmD (US Transplant MSL) have a conversation with Dr. Michael Verneris, MD. Dr. Verneris is a Professor of Pediatrics and the Barton Family Endowed Chair of Bone Marrow Transplant at the University of Colorado Denver School of Medicine. He also serves as the Director of Bone Marrow Transplantation and Cellular Therapy at the Children’s Hospital ...

In this episode our hosts Jason Yeh, PharmD (US Transplant MSL) and Katie McMurry, PharmD (US Transplant MSL) have a conversation with Dr. Sagar Patel, an Assistant Professor in the Transplant and Cellular Therapy Program at the Huntsman Cancer Institute in Salt Lake City, Utah. In this episode, Dr. Patel discusses current transplantation barriers observed in the diagnosis and treatment of chronic graft versus host disease, the exi...

In this episode our MSL co-hosts Yiota Manolopoulos, PharmD, MPH and Katie Mousavi, PharmD have a conversation with Anne Peters, MD on how to incorporate social determinants of health in clinical trials and methods to overcome the challenges that under resourced communities face daily. Dr. Peters identifies key barriers that physicians and other healthcare providers encounter when designing clinical trials for patients with diabete...

In this episode our hosts Sara Hammad, PharmD (US Transplant Associate Medical Director) and Ryan Bookout, PharmD (US Transplant MSL) have a conversation with Dr. Joseph Scalea, MD. Dr. Scalea is the inaugural Vice Chair of Innovation in the Department of Surgery, the Surgical Director of Kidney Transplant, and the Director of Hepatology, Nephrology, and Transplant ICCE Quality and Innovation at the Medical University of South Caro...

Join our Sanofi Medical co-hosts, Dalila Masic, Amulya Tatachar and Sara Hammad as we sit down with Subarna Malakar, Head of Diversity, Equity & Inclusion (DE&I) North America and Global Specialty Care at Sanofi. In this episode, Subarna speaks to personal experiences that relate to his passion for health equity. We also discuss Sanofi’s approach to DE&I, and Subarna’s role in leading these initiatives. 

Link to A Millio...

In this episode our co-hosts Sara Hammad, PharmD (US Transplant Associate Medical Director) and Tracy Chen, PharmD (US Transplant Senior MSL) have a conversation with Sumit Mohan, MD, MPH, a Professor of Medicine and Epidemiology at the Columbia University Medical Center, about disparities seen throughout the kidney transplant process. Dr. Mohan discusses the challenges seen with health disparities at all time points from a patient...

Join our Medical Science Liaison co-hosts, Amulya Tatachar and Erin Moline, and expert Dr. David Kerr, MBChB DM, FRCP, Director of Digital Health at the Diabetes Technology Society. Dr. Kerr will share more about democratization and discuss the importance of empowering people with diabetes through technology. In this episode, we will continue to build our conversation on trust and add this critical aspect of addressing health dispa...

Join our Medical Science Liaison co-hosts, Amulya Tatachar and Anil Jacob, and expert Donna Rice, MBA, BSN, RN, CDCES, FADCES as they discuss the fundamentals of building trust from an individual and population health standpoint. We will discuss how trust looks for the underserved communities, the role of patient advocates, and steps that you can take to eliminate implicit biases and gain trust with people with diabetes. We conclud...